Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Cti Biopharma Corp as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 145
- +12 vs. Q3 2022
- Shares held
- 105.1M
- +7.36M (+7.5%) vs. Q3 2022
- Total value
- $619.8M
- +$65.1M (+11.7%) vs. Q3 2022
- New holders
- 37
- 48 more added
- Sold out
- 25
- 37 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 2 | $474.2K |
| Q1 2023 | 133 | $475.2M |
| Q4 2022 | 145 | $619.8M |
| Q3 2022 | 133 | $554.7M |
| Q2 2022 | 119 | $510.1M |
| Q1 2022 | 92 | $344.9M |
| Q4 2021 | 63 | $118.3M |
| Q3 2021 | 56 | $159.6M |
| Q2 2021 | 50 | $133.1M |
| Q1 2021 | 55 | $126.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Cti Biopharma Corp; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 270,101 | $1.62M | 0.00% | +12,405+4.8% | Added |
| BNP Paribas Arbitrage, SA | 273,763 | $1.65M | 0.00% | −56,043−17.0% | Reduced |
| Tang Capital Management LLC | 300,000 | $1.80M | 0.26% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 308,813 | $1.86M | 0.03% | +308,813 | New |
| Sio Capital Management, LLC | 330,000 | $1.98M | 1.06% | +330,000 | New |
| Bank of New York Mellon Corp | 333,524 | $2.00M | 0.00% | −37,965−10.2% | Reduced |
| Worth Venture Partners, LLC | 364,995 | $2.19M | 1.30% | +364,995 | New |
| Susquehanna International Group, LLP | 423,104 | $2.54M | 0.00% | −220,888−34.3% | Reduced |
| Altium Capital Management LP | 450,000 | $2.70M | 1.38% | +23,000+5.4% | Added |
| Norges Bank | 488,100 | $2.93M | 0.00% | +488,100 | New |
| Knott David M Jr | 566,687 | $3.41M | 1.47% | 00.0% | Unchanged |
| J. Goldman & Co LP | 636,920 | $3.83M | 0.27% | +372,507+140.9% | Added |
| Citigroup Inc | 642,121 | $3.86M | 0.01% | −347,325−35.1% | Reduced |
| Morgan Stanley | 644,791 | $3.88M | 0.00% | −81,314−11.2% | Reduced |
| Barclays PLC | 758,361 | $4.56M | 0.00% | +79,748+11.8% | Added |
| Northern Trust Corp | 863,406 | $5.19M | 0.00% | +58,887+7.3% | Added |
| Balyasny Asset Management LLC | 871,409 | $5.24M | 0.02% | +871,409 | New |
| UBS Group AG | 926,309 | $5.57M | 0.00% | +782,053+542.1% | Added |
| Bank of America Corp | 926,363 | $5.57M | 0.00% | +211,300+29.5% | Added |
| Sectoral Asset Management Inc | 980,300 | $5.89M | 1.14% | +12,000+1.2% | Added |
| Two Sigma Advisers, LP | 1,026,567 | $6.17M | 0.02% | +82,454+8.7% | Added |
| JPMorgan Chase & Co | 1,186,030 | $7.13M | 0.00% | +46,920+4.1% | Added |
| Goldman Sachs Group Inc | 1,200,073 | $7.21M | 0.00% | −335,471−21.8% | Reduced |
| Nuveen Asset Management, LLC | 1,303,552 | $7.83M | 0.00% | −49,957−3.7% | Reduced |
| Ensign Peak Advisors, Inc | 1,326,062 | $7.97M | 0.02% | +619,785+87.8% | Added |
| AIGH Capital Management LLC | 1,405,859 | $8.45M | 2.79% | +1,405,859 | New |
| Parkman Healthcare Partners LLC | 1,408,642 | $8.47M | 2.25% | +198,497+16.4% | Added |
| Verition Fund Management LLC | 1,455,589 | $8.75M | 0.17% | +214,278+17.3% | Added |
| Rafferty Asset Management, LLC | 1,471,357 | $8.84M | 0.07% | +378,314+34.6% | Added |
| Schonfeld Strategic Advisors LLC | 1,747,600 | $10.5M | 0.09% | +418,124+31.5% | Added |
| Point72 Asset Management, L.P. | 1,757,800 | $10.6M | 0.04% | +1,649,890+1,529.0% | Added |
| Lion Point Capital, LP | 3,702,651 | $10.6M | 6.35% | −686,895−15.6% | Reduced |
| Ghost Tree Capital, LLC | 1,850,000 | $11.1M | 4.75% | −150,000−7.5% | Reduced |
| Geode Capital Management, LLC | 1,913,754 | $11.5M | 0.00% | +134,785+7.6% | Added |
| Wellington Management Group LLP | 2,758,903 | $16.6M | 0.00% | −60,760−2.2% | Reduced |
| NEA Management Company, LLC | 3,685,683 | $22.2M | 1.24% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,777,308 | $22.7M | 2.54% | +3,777,308 | New |
| Bleichroeder LP | 3,893,730 | $23.4M | 5.09% | −50,000−1.3% | Reduced |
| Sofinnova Investments, Inc. | 4,606,527 | $27.7M | 1.68% | +994,151+27.5% | Added |
| Millennium Management LLC | 4,762,769 | $28.6M | 0.03% | +8,641+0.2% | Added |
| Stonepine Capital Management, LLC | 4,934,100 | $29.7M | 12.47% | −735,288−13.0% | Reduced |
| Vanguard Group Inc | 5,571,411 | $33.5M | 0.00% | +785,388+16.4% | Added |
| BlackRock Inc. | 7,060,319 | $42.4M | 0.00% | +461,546+7.0% | Added |
| BVF Inc | 8,813,021 | $53.0M | 2.24% | 00.0% | Unchanged |
| State Street Corp | 16,002,989 | $96.2M | 0.01% | +2,260,435+16.4% | Added |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −1,633,541−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −1,580,934−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −735,165−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −470,576−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −357,303−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −233,452−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −189,303−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −107,192−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −96,992−100.0% | Sold out |
| Advisory Alpha, LLC | 0 | $0 | 0.00% | −78,717−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −68,516−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −67,400−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −63,512−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −48,834−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −34,578−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −34,566−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −26,520−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −22,639−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −19,263−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −17,571−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −17,415−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −10,624−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −7,426−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −540−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |